• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . BTN3A3 evasion promotes the zoonotic potential of influenza A viruses

tetano

Editor, Senior Moderator
Nature


. 2023 Jun 28.
doi: 10.1038/s41586-023-06261-8. Online ahead of print. BTN3A3 evasion promotes the zoonotic potential of influenza A viruses

Rute Maria Pinto[SUP] 1 2 [/SUP], Siddharth Bakshi[SUP] #[/SUP][SUP] 1 [/SUP], Spyros Lytras[SUP] #[/SUP][SUP] 1 [/SUP], Mohammad Khalid Zakaria[SUP] #[/SUP][SUP] 1 [/SUP], Simon Swingler[SUP] 1 [/SUP], Julie C Worrell[SUP] 3 [/SUP], Vanessa Herder[SUP] 1 [/SUP], Kerrie E Hargrave[SUP] 3 [/SUP], Margus Varjak[SUP] 1 4 [/SUP], Natalia Cameron-Ruiz[SUP] 1 [/SUP], Mila Collados Rodriguez[SUP] 1 [/SUP], Mariana Varela[SUP] 1 [/SUP], Arthur Wickenhagen[SUP] 1 [/SUP], Colin Loney[SUP] 1 [/SUP], Yanlong Pei[SUP] 5 [/SUP], Joseph Hughes[SUP] 1 [/SUP], Elise Valette[SUP] 1 [/SUP], Matthew L Turnbull[SUP] 1 [/SUP], Wilhelm Furnon[SUP] 1 [/SUP], Quan Gu[SUP] 1 [/SUP], Lauren Orr[SUP] 1 [/SUP], Aislynn Taggart[SUP] 1 [/SUP], Ola Diebold[SUP] 2 [/SUP], Chris Davis[SUP] 1 [/SUP], Chris Boutell[SUP] 1 [/SUP], Finn Grey[SUP] 2 [/SUP], Edward Hutchinson[SUP] 1 [/SUP], Paul Digard[SUP] 2 [/SUP], Isabella Monne[SUP] 6 [/SUP], Sarah K Wootton[SUP] 5 [/SUP], Megan K L MacLeod[SUP] 3 [/SUP], Sam J Wilson[SUP] 1 [/SUP], Massimo Palmarini[SUP] 7 [/SUP]



Affiliations
Abstract

Spillover events of avian influenza A viruses (IAVs) to humans could represent the first step in a future pandemic[SUP]1[/SUP]. Several factors that limit the transmission and replication of avian IAVs in mammals have been identified. There are several gaps in our understanding to predict which virus lineages are more likely to cross the species barrier and cause disease in humans[SUP]1[/SUP]. Here, we identified human BTN3A3 (butyrophilin subfamily 3 member A3)[SUP]2[/SUP] as a potent inhibitor of avian IAVs but not human IAVs. We determined that BTN3A3 is expressed in human airways and its antiviral activity evolved in primates. We show that BTN3A3 restriction acts primarily at the early stages of the virus life cycle by inhibiting avian IAV RNA replication. We identified residue 313 in the viral nucleoprotein (NP) as the genetic determinant of BTN3A3 sensitivity (313F or, rarely, 313L in avian viruses) or evasion (313Y or 313V in human viruses). However, avian IAV serotypes, such as H7 and H9, that spilled over into humans also evade BTN3A3 restriction. In these cases, BTN3A3 evasion is due to substitutions (N, H or Q) in NP residue 52 that is adjacent to residue 313 in the NP structure[SUP]3[/SUP]. Thus, sensitivity or resistance to BTN3A3 is another factor to consider in the risk assessment of the zoonotic potential of avian influenza viruses.


 
Back
Top